Feasibility study of dedicated breastPET(db PET) for evaluating therapeutic effects of primary systemic therapy (PST).

Feasibility study of dedicated breastPET(db PET) for evaluating therapeutic effects of primary systemic therapy (PST). - Feasibility study of dbPET

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007347

Enrollment

Registered

2012-03-01

Start date

2012-04-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

db PET

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Female patients with primary breast cancer diagnosed by palpation, imagings and cytology, with T stage >=T1and M0. 2.The patinets should be scheduled to receive PST. 3.Female patients who can agree to participate in this study of their own will, and aged 20 years and older at the time of informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with sever impairement in communications. 2. Patients with very poor general conditions (such as abnormal vital signs). 3. Patients who are pregnancy or suspicion of pregnancy. 4. Patients who are judged ineligible to enroll into this clinical study due to any reasons by the doctor.

Design outcomes

Primary

Measure	Time frame
FDG PET images on dbPET scan after the first cycle of PST.	—

Secondary

Measure	Time frame
Comparison between db PET and MRI or pathologic findings of resected specimen	—

Countries

Japan

Contacts

Public ContactTomoharu Sugie

Graduate School of Medicine Kyoto University Breast Surgery

sugie@kuhp.kyoto-u.ac.jp075-751-3660

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026